Olga Brawman-Mintzer to Depressive Disorder, Major
This is a "connection" page, showing publications Olga Brawman-Mintzer has written about Depressive Disorder, Major.
Connection Strength
0.215
-
A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults. J Clin Psychopharmacol. 2018 Aug; 38(4):336-343.
Score: 0.111
-
Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies. J Affect Disord. 2016 Dec; 206:151-160.
Score: 0.096
-
Generalized anxiety disorder in women. Psychiatr Clin North Am. 2001 Mar; 24(1):165-78.
Score: 0.008